Annual Cash & Cash Equivalents
$2.83 M
-$2.06 M-42.04%
31 December 2023
Summary:
ENDRA Life Sciences annual cash & cash equivalents is currently $2.83 million, with the most recent change of -$2.06 million (-42.04%) on 31 December 2023. During the last 3 years, it has fallen by -$6.63 million (-70.05%). NDRA annual cash & cash equivalents is now -70.05% below its all-time high of $9.46 million, reached on 31 December 2021.NDRA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$4.75 M
-$1.66 M-25.86%
30 September 2024
Summary:
ENDRA Life Sciences quarterly cash and cash equivalents is currently $4.75 million, with the most recent change of -$1.66 million (-25.86%) on 30 September 2024. Over the past year, it has increased by +$1.91 million (+67.44%). NDRA quarterly cash and cash equivalents is now -71.83% below its all-time high of $16.84 million, reached on 31 March 2021.NDRA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NDRA Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +67.4% |
| 3 y3 years | -70.0% | -49.9% |
| 5 y5 years | -54.1% | -23.1% |
NDRA Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -70.0% | at low | -57.9% | +318.2% |
| 5 y | 5 years | -70.0% | at low | -71.8% | +533.9% |
| alltime | all time | -70.0% | >+9999.0% | -71.8% | >+9999.0% |
ENDRA Life Sciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.75 M(-25.9%) |
| June 2024 | - | $6.40 M(+464.1%) |
| Mar 2024 | - | $1.13 M(-60.0%) |
| Dec 2023 | $2.83 M(-42.0%) | $2.83 M(-15.0%) |
| Sept 2023 | - | $3.33 M(-30.8%) |
| June 2023 | - | $4.82 M(+104.6%) |
| Mar 2023 | - | $2.36 M(-51.8%) |
| Dec 2022 | $4.89 M(-48.3%) | $4.89 M(-39.0%) |
| Sept 2022 | - | $8.02 M(-28.9%) |
| June 2022 | - | $11.28 M(+58.2%) |
| Mar 2022 | - | $7.13 M(-24.7%) |
| Dec 2021 | $9.46 M(+30.9%) | $9.46 M(-19.8%) |
| Sept 2021 | - | $11.79 M(-16.0%) |
| June 2021 | - | $14.04 M(-16.6%) |
| Mar 2021 | - | $16.84 M(+133.0%) |
| Dec 2020 | $7.23 M | $7.23 M(+90.5%) |
| Sept 2020 | - | $3.79 M(+406.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $748.60 K(-75.9%) |
| Mar 2020 | - | $3.10 M(-49.7%) |
| Dec 2019 | $6.17 M(-4.6%) | $6.17 M(+171.4%) |
| Sept 2019 | - | $2.28 M(+0.3%) |
| June 2019 | - | $2.27 M(-42.2%) |
| Mar 2019 | - | $3.93 M(-39.3%) |
| Dec 2018 | $6.47 M(+15.5%) | $6.47 M(+915.8%) |
| Sept 2018 | - | $637.10 K(-71.1%) |
| June 2018 | - | $2.21 M(-30.0%) |
| Mar 2018 | - | $3.15 M(-43.8%) |
| Dec 2017 | $5.60 M(+3763.4%) | $5.60 M(-19.7%) |
| Sept 2017 | - | $6.98 M(-7.3%) |
| June 2017 | - | $7.52 M(+5527.6%) |
| Mar 2017 | - | $133.70 K(-7.8%) |
| Dec 2016 | $145.00 K(+659.2%) | $145.00 K(+92.1%) |
| Sept 2016 | - | $75.50 K(+295.3%) |
| Dec 2015 | $19.10 K(-87.8%) | $19.10 K |
| Dec 2014 | $156.40 K | - |
FAQ
- What is ENDRA Life Sciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for ENDRA Life Sciences?
- What is ENDRA Life Sciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for ENDRA Life Sciences?
- What is ENDRA Life Sciences quarterly cash and cash equivalents year-on-year change?
What is ENDRA Life Sciences annual cash & cash equivalents?
The current annual cash & cash equivalents of NDRA is $2.83 M
What is the all time high annual cash & cash equivalents for ENDRA Life Sciences?
ENDRA Life Sciences all-time high annual cash & cash equivalents is $9.46 M
What is ENDRA Life Sciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NDRA is $4.75 M
What is the all time high quarterly cash and cash equivalents for ENDRA Life Sciences?
ENDRA Life Sciences all-time high quarterly cash and cash equivalents is $16.84 M
What is ENDRA Life Sciences quarterly cash and cash equivalents year-on-year change?
Over the past year, NDRA quarterly cash and cash equivalents has changed by +$1.91 M (+67.44%)